Mawson Infrastructure Group Inc. Files 8-K
Ticker: MIGI · Form: 8-K · Filed: Sep 17, 2025 · CIK: 1218683
Sentiment: neutral
Topics: 8-K, disclosure, financials
Related Tickers: MIGI
TL;DR
Mawson Infrastructure Group (MIGI) filed an 8-K on 9/17 for events on 9/12 - includes Reg FD, other events, and financials.
AI Summary
Mawson Infrastructure Group Inc. filed an 8-K on September 17, 2025, reporting events that occurred on September 12, 2025. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, formerly known as Wize Pharma, Inc., is incorporated in Delaware and headquartered in Midland, Pennsylvania.
Why It Matters
This 8-K filing provides updates on the company's activities and financial reporting, which are crucial for investors to understand its current status and potential future performance.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting standard corporate events and disclosures, not indicating immediate significant financial distress or major operational changes.
Key Players & Entities
- Mawson Infrastructure Group Inc. (company) — Registrant
- Wize Pharma, Inc. (company) — Former company name
- September 12, 2025 (date) — Earliest event reported date
- September 17, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Midland, Pennsylvania (location) — Business address
FAQ
What specific events are being disclosed under 'Other Events'?
The filing indicates 'Other Events' as a category, but the specific details of these events are not provided in the provided text snippet.
What is the significance of the 'Regulation FD Disclosure' item?
This indicates that the company is making public disclosures to ensure that material non-public information is disseminated broadly, in compliance with Regulation Fair Disclosure.
What type of financial statements are included in this filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific nature or period of these financial statements is not detailed in the provided text.
When was Mawson Infrastructure Group Inc. previously known as Wize Pharma, Inc.?
The filing states the date of the name change from Wize Pharma, Inc. to Mawson Infrastructure Group Inc. was November 20, 2017.
What is the company's fiscal year end?
The company's fiscal year ends on December 31st.
Filing Stats: 1,437 words · 6 min read · ~5 pages · Grade level 13.7 · Accepted 2025-09-17 16:50:53
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value MIGI The Nasdaq Stock Market
- $35.0 million — d Securities ("MVLS") was less than the $35.0 million minimum required for continued listing
- $1.00 — ompany's common stock was less than the $1.00 per share minimum bid price required fo
Filing Documents
- f8k_091725.htm (8-K) — 23KB
- exh_991.htm (EX-99.1) — 6KB
- exh_992.htm (EX-99.2) — 30KB
- exh992_01.jpg (GRAPHIC) — 271KB
- exh992_02.jpg (GRAPHIC) — 186KB
- exh992_03.jpg (GRAPHIC) — 133KB
- exh992_04.jpg (GRAPHIC) — 152KB
- exh992_05.jpg (GRAPHIC) — 164KB
- exh992_06.jpg (GRAPHIC) — 167KB
- exh992_07.jpg (GRAPHIC) — 185KB
- exh992_08.jpg (GRAPHIC) — 170KB
- exh992_09.jpg (GRAPHIC) — 193KB
- exh992_10.jpg (GRAPHIC) — 173KB
- exh992_11.jpg (GRAPHIC) — 164KB
- exh992_12.jpg (GRAPHIC) — 165KB
- exh992_13.jpg (GRAPHIC) — 160KB
- exh992_14.jpg (GRAPHIC) — 167KB
- exh992_15.jpg (GRAPHIC) — 138KB
- exh992_16.jpg (GRAPHIC) — 174KB
- exh992_17.jpg (GRAPHIC) — 227KB
- 0001171843-25-005942.txt ( ) — 4387KB
- gnw-20250101.xsd (EX-101.SCH) — 3KB
- gnw-20250101_def.xml (EX-101.DEF) — 25KB
- gnw-20250101_lab.xml (EX-101.LAB) — 35KB
- gnw-20250101_pre.xml (EX-101.PRE) — 24KB
- f8k_091725_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On September 17, 2025, Mawson Infrastructure Group Inc. (the "Company") issued a press release providing a corporate update to stockholders and the investment community regarding the Company's current operations. The Company also provided an updated Company Presentation, which it has made available on its website at www.mawsoninc.com. Copies of the press release and the Company Presentation are furnished as Exhibits 99.1 and 99.2, respectively, hereto and are incorporated herein by reference. By filing this Current Report on Form 8-K and furnishing the information contained herein, the Company makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD. The information presented in Item 7.01 of this Current Report on Form 8-K and Exhibits 99.1 and 99.2 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered "filed" under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.
01. Other Events
Item 8.01. Other Events. On September 12, 2025, the Company received written notice (the "Notice") from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that the Nasdaq Hearings Panel (the "Panel"), based on the compliance plan presented by the Company, has determined to grant the Company's request for continued listing on Nasdaq, subject to the Company satisfying certain conditions. As previously disclosed, on January 24, 2025, the Company received written notice (the "MVLS Notice") from the Staff notifying the Company that for the 33 consecutive business days preceding the date of the MVLS Notice, the Company's Market Value of Listed Securities ("MVLS") was less than the $35.0 million minimum required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the "MVLS Rule"). On February 6, 2025, the Company received written notice (the "Bid Price Notice") from the Staff notifying the Company that for the last 30 consecutive business days prior to the date of the Bid Price Notice, the closing bid price of the Company's common stock was less than the $1.00 per share minimum bid price required for continued listing on The Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule"). The Panel granted the Company's request to extend the period of time in which to demonstrate compliance with (i) the MVLS Rule to October 15, 2025 and (ii) the Bid Price Rule to November 7, 2025 (the "Exception Period"). Pursuant to the Notice, the conditions for the Company's continued listing during the Exception Period include that the Company provide Nasdaq prompt notification of any significant events that occur during this time that may affect the Company's compliance with Nasdaq requirements. The Panel reserves the right to reconsider the terms of the exception based on any event, condition or circumstance that exists or develops that would, in the o
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated September 17, 2025 99.2 Company Presentation dated September 17, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Mawson Infrastructure Group Inc. Date: September 17, 2025 By: /s/ Kaliste Saloom Kaliste Saloom Interim Chief Executive Officer, General Counsel and Corporate Secretary